Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Palisade Bio, Inc. (PALI : NSDQ)

• Company Description    Palisade Bio Inc. is a late-stage biopharma company advancing therapies which help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio Inc., formerly known as Seneca Biopharma Inc., is based in CARLSBAD, Calif. Number of Employees: 13

• Price / Volume Information    Yesterday's Closing Price: $0.52 Daily Weekly Monthly 20 Day Moving Average: 361,523 shares Shares Outstanding: 21.88 (millions) Market Capitalization: $11.38 (millions) Beta: 1.63 52 Week High: $4.57 52 Week Low: $0.40 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -42.11% -36.61% 12 Week -43.48% -36.48% Year To Date -60.00% -51.13%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5800 Armada Drive Suite 210 - Carlsbad,CA 92008 USA ph: 858-704-4900 fax: - ir@palisadebio.com http://www.palisadebio.com

• General Corporate Information    Officers Thomas M. Hallam - Chief Executive Officer and Director James R. Neal - Chairman J.D. Finley - Chief Financial Officer Cristina Csimma - Director Stephanie Diaz - Director Peer Information Palisade Bio, Inc. (CORR.) Palisade Bio, Inc. (RSPI) Palisade Bio, Inc. (CGXP) Palisade Bio, Inc. (BGEN) Palisade Bio, Inc. (GTBP) Palisade Bio, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 696389105 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/23/22 Share - Related Items Shares Outstanding: 21.88 Most Recent Split Date: 4.00 (0.17:1) Beta: 1.63 Market Capitalization: $11.38 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.57 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/23/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.98 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -135.14% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - -2,145.95 12/31/21 - -1,479.63 09/30/21 - - ROA 03/31/22 - -273.04 12/31/21 - -268.78 09/30/21 - -378.80 Current Ratio 03/31/22 - 4.43 12/31/21 - 4.96 09/30/21 - 5.51 Quick Ratio 03/31/22 - 4.43 12/31/21 - 4.96 09/30/21 - 5.51 Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - -891,833.38 Book Value 03/31/22 - 0.26 12/31/21 - 0.52 09/30/21 - 0.30 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00

Powered by Zacks Investment Research ©